| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | -34.0% | -19.7% |
| Cost of Revenue | $2.1M | -27.8% | -26.8% |
| Gross Profit | -$198K | -530.4% | +60.3% |
| R&D Expense | $160K | -75.3% | -42.3% |
| Operating Income | -$3.7M | +12.3% | -253.6% |
| Pre-tax Income | -$5.2M | +71.2% | -199.2% |
| Net Income | -$5.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $722K | +58.0% | +465.6% |
| Accounts Receivable | $721K | -52.2% | — |
| Inventory | $3.6M | -2.0% | -33.2% |
| Current Assets | $9.0M | -22.4% | +21.6% |
| Total Assets | $31.7M | +111.2% | +258.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | — |
| Investing Cash Flow | -$142K | — | — |
| Financing Cash Flow | $8.2M | — | — |
| +71.2% |
| -199.2% |
| EPS (Basic) | -$32.44 | -507.5% | -4741.8% |
| EPS (Diluted) | -$32.44 | -507.5% | -4741.8% |
| $26.7M |
| +63.9% |
| +118.6% |
| Total Liabilities | $28.4M | +56.2% | +123.7% |
| Stockholders' Equity | $3.4M | +208.0% | +188.2% |